Item |
Information |
Drug Groups
|
withdrawn |
Description
|
Zomepirac, formerly marketed as Zomax tablets, was associated with fatal and near-fatal anaphylactoid reactions. The manufacturer voluntarily removed Zomax tablets from the Canadian, US, and UK markets in March 1983. |
Indication |
Zomepirac was indicated for the management of mild to severe pain. |
Affected Organisms |
• |
Humans and other mammals |
|
External Links |
|
|